Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Cyclonex |
| Active Ingredient: | Cyclophosphamide monohydrate 53.5mg equivalent to cyclophosphamide 50mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | CARSL Consulting |
| Manufacturer: | Idifarma Desarrollo Farmaceutico S.L, Noain, Spain |
| Product: | Ketamine |
| Active Ingredient: | Ketamine hydrochloride 1.153mg/mL equivalent to ketamine 1mg/mL |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Product: | Ketamine |
| Active Ingredient: | Ketamine hydrochloride 11.53mg/mL equivalent to ketamine 10mg/mL |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Product: | Zematop |
| Active Ingredient: | Tacrolimus monohydrate 1.022mg/g equivalent to tacrolimus 1mg/g |
| Dosage Form: | Topical ointment |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Intas Pharmaceuticals Limited, Sanand, India |
Dated this 6th day of April 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).